Stockholder Alert: Robbins LLP Informs Investors of the ESS Pharma Inc. Class Action
Portfolio Pulse from
Robbins LLP has announced a class action lawsuit against ESSA Pharma Inc. for investors who acquired its securities between December 12, 2023, and October 31, 2024. ESSA Pharma is a clinical-stage pharmaceutical company focused on prostate cancer treatments.
January 27, 2025 | 5:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A class action lawsuit has been filed against ESSA Pharma Inc. for investors who acquired its securities between December 12, 2023, and October 31, 2024. This legal action could impact the company's stock price.
The announcement of a class action lawsuit typically has a negative impact on a company's stock price due to potential legal liabilities and associated costs. Investors may react negatively, leading to a short-term decline in stock value.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100